These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 33733021)

  • 1. Care cascade for patients with opioid use disorder and serious injection related infections.
    Upadhyaya A; Marks LR; Schwarz ES; Liang SY; Durkin MJ; Liss DB
    Toxicol Commun; 2021; 5(1):6-10. PubMed ID: 33733021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and protocol of the Buprenorphine plus Outpatient Parenteral Antimicrobial Therapy (B-OPAT) study: a randomized clinical trial of integrated outpatient treatment of opioid use disorder and severe, injection-related infections.
    Fanucchi LC; Murphy SM; Surratt H; Kapadia SN; Walsh SL; Grubbs JA; Thornton AC; Nuzzo P; Lofwall MR
    Ther Adv Infect Dis; 2022; 9():20499361221108005. PubMed ID: 35847566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harm reduction for the treatment of patients with severe injection-related infections: description of the Jackson SIRI Team.
    Serota DP; Tookes HE; Hervera B; Gayle BM; Roeck CR; Suarez E; Forrest DW; Kolber MA; Bartholomew TS; Rodriguez AE; Doblecki-Lewis S
    Ann Med; 2021 Dec; 53(1):1960-1968. PubMed ID: 34726095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Study Protocol to Increase Engagement in Evidence Based Hospital and Community Based Care Using a Serious Injection Related Infections (SIRI) Checklist and Enhanced Peer for Hospitalized PWID (ShaPe).
    Baldwin M; Jeziorski M; Parman M; Gagnon K; Nichols MA; Bradford D; Crockett K; Eaton E
    Res Sq; 2023 Jun; ():. PubMed ID: 37333109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients With Serious Injection Drug Use-Related Infections who Experience Patient-Directed Discharges on Oral Antibiotics Have High Rates of Antibiotic Adherence but Require Multidisciplinary Outpatient Support for Retention in Care.
    Lewis S; Liang SY; Schwarz ES; Liss DB; Winograd RP; Nolan NS; Durkin MJ; Marks LR
    Open Forum Infect Dis; 2022 Feb; 9(2):ofab633. PubMed ID: 35106316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methamphetamines and Serious Injection-Related Infections: Opioid Use Care Continuum and Opportunities to End Alabama's Drug Crisis.
    Levy S; Bassler J; Gagnon K; Prados M; Jeziorski M; McCleskey B; Crockett K; Li L; Bradford D; Cropsey K; Eaton E
    Open Forum Infect Dis; 2023 Jan; 10(1):ofac708. PubMed ID: 36726543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparison of Medication for Opioid Use Disorder Treatment Strategies for Persons Who Inject Drugs With Invasive Bacterial and Fungal Infections.
    Marks LR; Munigala S; Warren DK; Liss DB; Liang SY; Schwarz ES; Durkin MJ
    J Infect Dis; 2020 Sep; 222(Suppl 5):S513-S520. PubMed ID: 32877547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid Use Disorder Increases 30-Day Readmission Risk in Inflammatory Bowel Disease Hospitalizations: a Nationwide Matched Analysis.
    Charilaou P; Mohapatra S; Joshi T; Devani K; Gadiparthi C; Pitchumoni CS; Goldstein D
    J Crohns Colitis; 2020 Jun; 14(5):636-645. PubMed ID: 31804682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a Nurse-Led Program for Rural Pregnant Women With Opioid Use Disorder to Improve Maternal-Neonatal Outcomes.
    Paterno MT; Jablonski L; Klepacki A; Friedmann PD
    J Obstet Gynecol Neonatal Nurs; 2019 Sep; 48(5):495-506. PubMed ID: 31374181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experiences of care among individuals with opioid use disorder-associated endocarditis and their healthcare providers: Results from a qualitative study.
    Bearnot B; Mitton JA; Hayden M; Park ER
    J Subst Abuse Treat; 2019 Jul; 102():16-22. PubMed ID: 31202284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated Infectious Disease and Substance Use Disorder Care for the Treatment of Injection Drug Use-Associated Infections: A Prospective Cohort Study With Historical Control.
    Serota DP; Rosenbloom L; Hervera B; Seo G; Feaster DJ; Metsch LR; Suarez E; Chueng TA; Hernandez S; Rodriguez AE; Tookes HE; Doblecki-Lewis S; Bartholomew TS
    Open Forum Infect Dis; 2023 Jan; 10(1):ofac688. PubMed ID: 36632415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid use disorder in admissions for acute exacerbations of chronic pancreatitis and 30-day readmission risk: A nationwide matched analysis.
    Charilaou P; Mohapatra S; Joshi T; Devani K; Gadiparthi C; Pitchumoni CS; Broder A
    Pancreatology; 2020 Jan; 20(1):35-43. PubMed ID: 31759905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of initiation of medications for opioid use disorder on hospitalization outcomes for endocarditis and osteomyelitis in a large private hospital system in the United States, 2014-18.
    Jo Y; Nosal R; Vittori A; Cordova L; Vandever C; Alvarez C; Bartholomew TS; Tookes HE
    Addiction; 2021 Aug; 116(8):2127-2134. PubMed ID: 33394516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining a recovery-oriented cascade of care for opioid use disorder: A community-driven, statewide cross-sectional assessment.
    Yedinak JL; Goedel WC; Paull K; Lebeau R; Krieger MS; Thompson C; Buchanan AL; Coderre T; Boss R; Rich JD; Marshall BDL
    PLoS Med; 2019 Nov; 16(11):e1002963. PubMed ID: 31743335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of Opioid Use on Thromboembolic Complications, Readmission Rates, and 90-Day Episode of Care Costs After Total Hip Arthroplasty.
    Sodhi N; Anis HK; Acuña AJ; Vakharia RM; Piuzzi NS; Higuera CA; Roche MW; Mont MA
    J Arthroplasty; 2020 Jun; 35(6S):S237-S240. PubMed ID: 32197965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing a remotely delivered intensive outpatient program adapted for hospitalized patients with opioid use disorder: A qualitative study.
    Szpak V; Prostko S; Weiss RD; Suzuki J
    Addict Behav Rep; 2024 Jun; 19():100546. PubMed ID: 38680207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated outpatient treatment of opioid use disorder and injection-related infections: A description of a new care model.
    Fanucchi LC; Walsh SL; Thornton AC; Lofwall MR
    Prev Med; 2019 Nov; 128():105760. PubMed ID: 31251946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
    Sohn M; Talbert JC; Huang Z; Oser C; Freeman PR
    Pain Physician; 2021 Mar; 24(2):E249-E256. PubMed ID: 33740362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an Emergency Department-Based Intervention to Expand Access to Medications for Opioid Use Disorder in a Medicaid Nonexpansion Setting: Protocol for Engagement and Community Collaboration.
    Walter LA; Li L; Rodgers JB; Hess JJ; Skains RM; Delaney MC; Booth J; Hess EP
    JMIR Res Protoc; 2021 Apr; 10(4):e18734. PubMed ID: 33913818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Inpatient Medication-Assisted Therapy on Against-Medical-Advice Discharge and Readmission Rates.
    Wang SJ; Wade E; Towle J; Hachey T; Rioux J; Samuels O; Bonner C; Kirkpatrick C; O'Loughlin S; Foster K
    Am J Med; 2020 Nov; 133(11):1343-1349. PubMed ID: 32445720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.